logoTry Persana

Instapath Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Instapath Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Instapath Inc. company logo

Instapath was founded to revolutionize the pathology industry, enabling fast and accurate biological sample evaluation at the point of care.

HeadquartersHouston, United States
Team size1-10
Founded2017

What is Instapath Inc.? - Company Overview & Details

Instapath Inc. is Instapath was founded to revolutionize the pathology industry, enabling fast and accurate biological sample evaluation at the point of care. Founded in 2017, the company is headquartered in Houston, United States.

Who Founded Instapath Inc.?

Instapath Inc. was founded by Mei Wang.

Who are the Key Executives at Instapath Inc.? - Leadership Team

Instapath Inc. is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Instapath Inc.

Mei WangCEO

Chief Technology Officer (CTO) of Instapath Inc.

CTO

About Mei Wang - CEO of Instapath Inc.

Mei Wang serves as the Chief Executive Officer of Instapath Inc., leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Instapath Inc. Company Details & Key Information

Where is Instapath Inc. located?

Instapath Inc. is headquartered in Houston, United States.

How many employees does Instapath Inc. have?

Instapath Inc. has 1-10 employees.

When was Instapath Inc. founded?

Instapath Inc. was founded in 2017.

Instapath Inc. Official Website

How much funding has Instapath Inc. raised?

Instapath Inc. has raised $1.7 Million across 6 funding rounds. The most recent funding was completed on 2019-09-17.

Funding Overview

Instapath raised $1.7 million in a Series Seed round to enhance its operations.

$1.7 Million
Total Funding Raised
6
Funding Rounds
2019-09-17
Latest Round

Instapath Inc. Funding History

Series Seed
2019-09-17
$1.7 Million

Who are the key investors in Instapath Inc.?

Instapath Inc. is backed by 1 key investors including Draper Associates. These investors focus on Biotechnology, Medical Devices sectors.

Instapath Inc. Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Instapath Inc. Investors

Draper Associates

Investment firm known for supporting early-stage companies.

Investment Focus
Biotechnology
Medical Devices
Notable Portfolio Companies
Instapath Inc.

What sectors do Instapath Inc. investors focus on?

The investors backing Instapath Inc. primarily focus on Biotechnology, Medical Devices sectors.

Biotechnology
Medical Devices

Featured Investor: Draper Associates

Draper Associates

Investment firm known for supporting early-stage companies.

Notable Investments: Instapath Inc.

What are Instapath Inc.'s future plans?

Instapath Inc. Strategic Outlook

Strategic Focus
In Development
2
Key Challenges
2
Growth Opportunities

What challenges does Instapath Inc. face?

Instapath Inc. has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Instapath Inc.

1

Scaling operations

2

Attracting more investment

What opportunities does Instapath Inc. have?

Instapath Inc. has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Instapath Inc.

1

Expanding product offerings

2

Entering new markets

Instapath Inc. Strategic Position Summary

Key Focus Areas

Instapath Inc. is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Instapath Inc.?

Instapath Inc. has 2 recent news updates covering key business developments and market activities.

Instapath Inc. News Overview

2
Recent Articles
Active
Media Coverage
2019-09-16
Latest Update

What is Instapath Inc. in the news for?

Instapath Inc. is currently featured in news for Instapath Inc received financing of $1.7M in Seed on Sep 17th '19. and other significant business developments.

Recent News Articles About Instapath Inc.

Article 1
2019-09-16

Instapath Inc received financing of $1.7M in Seed on Sep 17th '19.

Instapath raised $1.7 million in a Series Seed round led by Draper Associates.

instapathbio.com
Read News
Article 2
2025-05-22

Instapath awarded funding from CPRIT.

Instapath has been awarded funding from CPRIT to support cancer research.

cprit.texas.gov
Read News

Instapath Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Instapath Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Instapath Inc. Questions & Answers - Company Information

Q1

What is Instapath Inc.?

Instapath was founded to revolutionize the pathology industry, enabling fast and accurate biological sample evaluation at the point of care.

Q2

Who founded Instapath Inc.?

Instapath Inc. was founded by Mei Wang.

Q3

Who is the CEO of Instapath Inc.?

The CEO of Instapath Inc. is Mei Wang. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Instapath Inc. raised?

Instapath Inc. has raised a total of $$1.7 Million across 6 funding rounds. The most recent funding was completed on 2019-09-17.

Q5

Who are the investors in Instapath Inc.?

Instapath Inc.'s key investors include Draper Associates.

Q6

Where is Instapath Inc. headquartered?

Instapath Inc. is headquartered in Houston, United States.

Q7

When was Instapath Inc. founded?

Instapath Inc. was founded in 2017.

Q8

How many employees does Instapath Inc. have?

Instapath Inc. has 1-10 employees.

Q9

What is Instapath Inc.'s official website?

You can visit Instapath Inc.'s official website at http://instapathbio.com/.

Q10

What was Instapath Inc.'s latest funding round?

Instapath Inc.'s latest funding round was a Series Seed round of $$1.7 Million completed on 2019-09-17.

Q11

Who is founder?

Mei Wang

Q12

What does the company do?

Instapath enables fast and accurate biological sample evaluation at the point of care.

Q13

How much funding?

$1.7 Million

Q14

Latest funding date?

2019-09-17

Q15

Who are the investors?

Draper Associates

Q16

What are the challenges?

Scaling operations Attracting more investment

Q17

What are the opportunities?

Expanding product offerings Entering new markets

Q18

Latest news?

Instapath raised $1.7 million in a Series Seed round led by Draper Associates. Instapath has been awarded funding from CPRIT to support cancer research.

More Information About Instapath Inc.

For additional details about Instapath Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.